Trading Signals: CEMI Stock Price Prediction and Forecast (Wed. Nov. 26, 2003 - Wed. Jul. 21, 2021)(Chembio Diagnostics Inc)
| CEMI latest price $5.5000 (-0.54%) ($5.4500 - $5.9000) on Thu. Oct. 17, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.26% (three month average) | RSI | 24 | Latest Price | $5.5000(-0.54%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | CEMI declines -3.2% a week on average for past two weeks. | Market Behavior | Normal for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support CEMI advance at 0% a week (0% probability) UNG(21%) IGOV(7%) USO(7%) XAR(7%) XRT(6%) | Factors Impacting CEMI price | CEMI will decline at least -1.63% in a week (0% probabilities). URA(-10%) IPO(-7%) JNK(-6%) HYG(-6%) BLOK(-6%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.63% (StdDev 3.26%) | Hourly BBV | 0 () | Intraday Trend | 0.2% | | | |
|
1 - 5 Day Possible Target | $-16.26(-395.64%) | Resistance Level | $5.99 | 5 Day Moving Average | $5.53(-0.54%) | 10 Day Moving Average | $5.54(-0.72%) | 20 Day Moving Average | $5.99(-8.18%) | To recent high | -24.1% | To recent low | 9.1% | Market Cap | $111m | | | | Chembio Diagnostics, Inc. develops, manufactures, markets and licenses rapid point-of-care diagnostic tests that detect infectious diseases. The firm expanding its product portfolio based upon the proprietary Dual Path Platform, which uses a small drop of blood from the fingertip to provide cost-effective diagnostic results in approximately 15 minutes. Its products include human and veterinary diagnostics. The company was founded in 1985 and is headquartered in Hauppauge, NY. |